News & Updates

Daratumumab-containing regimens safe, effective against multiple myeloma
Daratumumab-containing regimens safe, effective against multiple myeloma
21 Nov 2021

Adding daratumumab to backbone treatments against multiple myeloma (MM) yields high clinical efficacy and has an acceptable toxicity profile, a recent study has found. Such regimens are good treatment options for newly diagnosed (ND) and relapsed/refractory (RR) MM.

Daratumumab-containing regimens safe, effective against multiple myeloma
21 Nov 2021
MRI/ultrasound fusion biopsy accurately detects PCa in men with intermediate PSA
MRI/ultrasound fusion biopsy accurately detects PCa in men with intermediate PSA
19 Nov 2021
Statins reduce hepatocellular carcinoma risk in cirrhotic patients
Statins reduce hepatocellular carcinoma risk in cirrhotic patients
17 Nov 2021

The risk of hepatocellular carcinoma (HCC) among patients with nonalcoholic steatohepatitis (NASH) and bridging fibrosis is low, reveals a recent study. In addition, dose-dependent statin can substantially lower the risk of HCC in patients with NASH cirrhosis.

Statins reduce hepatocellular carcinoma risk in cirrhotic patients
17 Nov 2021
Drinking green tea improves gastrointestinal function recovery after gastrectomy
Drinking green tea improves gastrointestinal function recovery after gastrectomy
15 Nov 2021 byStephen Padilla

Patients with gastric cancer who drink green tea following robotic or laparoscopic subtotal gastrectomy show enhanced postoperative recovery of gastrointestinal function, reveals a study.

Drinking green tea improves gastrointestinal function recovery after gastrectomy
15 Nov 2021